Jacobs Levy Equity Management Inc. Sells 8,812 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Jacobs Levy Equity Management Inc. lessened its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 11.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 68,866 shares of the company's stock after selling 8,812 shares during the period. Jacobs Levy Equity Management Inc.'s holdings in Ryan Specialty were worth $4,418,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of RYAN. Raymond James Financial Inc. bought a new position in shares of Ryan Specialty in the 4th quarter valued at about $94,484,000. Norges Bank bought a new position in shares of Ryan Specialty in the 4th quarter valued at about $78,358,000. Principal Financial Group Inc. grew its position in shares of Ryan Specialty by 115.2% in the 4th quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company's stock valued at $117,619,000 after acquiring an additional 981,505 shares during the period. CIBC Private Wealth Group LLC grew its position in shares of Ryan Specialty by 6,911.0% in the 4th quarter. CIBC Private Wealth Group LLC now owns 785,928 shares of the company's stock valued at $48,036,000 after acquiring an additional 774,718 shares during the period. Finally, Vanguard Group Inc. grew its position in shares of Ryan Specialty by 5.7% in the 4th quarter. Vanguard Group Inc. now owns 9,880,504 shares of the company's stock valued at $633,933,000 after acquiring an additional 529,631 shares during the period. Institutional investors own 84.82% of the company's stock.

Ryan Specialty Stock Performance

Ryan Specialty stock traded up $0.27 during midday trading on Tuesday, hitting $70.60. The company's stock had a trading volume of 74,813 shares, compared to its average volume of 976,592. Ryan Specialty Holdings, Inc. has a 1-year low of $52.34 and a 1-year high of $77.16. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The company has a 50-day moving average price of $70.18 and a two-hundred day moving average price of $68.77. The company has a market cap of $18.53 billion, a price-to-earnings ratio of 102.42, a PEG ratio of 1.19 and a beta of 0.68.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.39 earnings per share for the quarter, hitting the consensus estimate of $0.39. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The business had revenue of $690.17 million during the quarter, compared to analysts' expectations of $680.80 million. During the same quarter in the previous year, the company earned $0.35 EPS. The business's revenue was up 25.0% on a year-over-year basis. As a group, sell-side analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th will be paid a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 0.68%. The ex-dividend date is Tuesday, May 13th. Ryan Specialty's dividend payout ratio (DPR) is 141.18%.

Insiders Place Their Bets

In other Ryan Specialty news, EVP Brendan Martin Mulshine sold 30,000 shares of the firm's stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 11.10% of the company's stock.

Analysts Set New Price Targets

RYAN has been the subject of a number of analyst reports. Barclays decreased their price objective on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a research report on Friday, April 11th. Wells Fargo & Company decreased their price objective on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a research report on Thursday, April 10th. Morgan Stanley raised their target price on shares of Ryan Specialty from $78.00 to $80.00 and gave the stock an "overweight" rating in a research note on Monday. TD Cowen began coverage on shares of Ryan Specialty in a research note on Thursday, April 10th. They set a "buy" rating and a $89.00 target price for the company. Finally, UBS Group raised their target price on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $75.58.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.